Victor G. Vogel

28.6k total citations · 5 hit papers
173 papers, 16.1k citations indexed

About

Victor G. Vogel is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, Victor G. Vogel has authored 173 papers receiving a total of 16.1k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Oncology, 94 papers in Genetics and 62 papers in Cancer Research. Recurrent topics in Victor G. Vogel's work include Cancer Risks and Factors (65 papers), Estrogen and related hormone effects (56 papers) and Breast Cancer Treatment Studies (56 papers). Victor G. Vogel is often cited by papers focused on Cancer Risks and Factors (65 papers), Estrogen and related hormone effects (56 papers) and Breast Cancer Treatment Studies (56 papers). Victor G. Vogel collaborates with scholars based in United States, Canada and United Kingdom. Victor G. Vogel's co-authors include Joseph P. Costantino, Norman Wolmark, D. Lawrence Wickerham, André Robidoux, Leslie G. Ford, James N. Atkins, Walter M. Cronin, Elizabeth Tan-Chiu, Maureen Kavanah and Nikolay Dimitrov and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Victor G. Vogel

163 papers receiving 15.5k citations

Hit Papers

Tamoxifen for Prevention of Breast Cancer: Report of the ... 1987 2026 2000 2013 1998 2008 2006 1987 2005 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
    1998 4.0k citations Joseph P. Costantino, D. Lawrence Wickerham et al. profile →
  2. Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
    2008 1.3k citations Priya Rastogi, Charles E. Geyer et al. Journal of Clinical Oncology profile →
  3. Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes<SUBTITLE>The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial</SUBTITLE>
    2006 1.1k citations Victor G. Vogel JAMA profile →
  4. VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATION
    1987 673 citations Victor G. Vogel et al. profile →
  5. Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: NSABP B-31
    2005 568 citations Elizabeth Tan-Chiu, Greg Yothers et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Victor G. Vogel United States 49 8.0k 6.7k 5.5k 2.4k 2.3k 173 16.1k
John Forbes United Kingdom 59 8.2k 1.0× 5.9k 0.9× 6.7k 1.2× 2.1k 0.9× 1.7k 0.7× 202 16.5k
Vered Stearns United States 57 6.6k 0.8× 4.6k 0.7× 4.3k 0.8× 2.9k 1.2× 1.7k 0.7× 327 14.0k
Claudine Isaacs United States 63 4.8k 0.6× 7.9k 1.2× 3.7k 0.7× 2.7k 1.2× 2.0k 0.9× 279 13.8k
Michael Baum United Kingdom 53 6.3k 0.8× 3.5k 0.5× 5.8k 1.0× 2.2k 0.9× 1.6k 0.7× 283 13.3k
Thomas A. Sellers United States 68 6.3k 0.8× 4.5k 0.7× 4.4k 0.8× 3.7k 1.6× 3.0k 1.3× 279 16.1k
James N. Atkins United States 47 8.3k 1.0× 3.9k 0.6× 4.4k 0.8× 2.6k 1.1× 2.0k 0.9× 107 14.4k
Beat Thürlimann Switzerland 57 10.9k 1.4× 5.5k 0.8× 10.1k 1.8× 2.9k 1.2× 3.0k 1.3× 214 17.9k
André Robidoux Canada 36 7.7k 1.0× 4.4k 0.7× 8.0k 1.5× 2.2k 0.9× 4.1k 1.8× 89 14.7k
Kathleen E. Malone United States 63 7.2k 0.9× 3.9k 0.6× 4.0k 0.7× 2.7k 1.1× 1.4k 0.6× 221 12.3k
Paul E. Goss United States 47 5.4k 0.7× 3.7k 0.5× 3.8k 0.7× 2.3k 1.0× 968 0.4× 214 10.6k

Countries citing papers authored by Victor G. Vogel

Since Specialization
Citations

This map shows the geographic impact of Victor G. Vogel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victor G. Vogel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victor G. Vogel more than expected).

Fields of papers citing papers by Victor G. Vogel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victor G. Vogel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victor G. Vogel. The network helps show where Victor G. Vogel may publish in the future.

Co-authorship network of co-authors of Victor G. Vogel

This figure shows the co-authorship network connecting the top 25 collaborators of Victor G. Vogel. A scholar is included among the top collaborators of Victor G. Vogel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victor G. Vogel. Victor G. Vogel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mohile, Supriya G., Mary Whitehead, Victor G. Vogel, et al.. (2023). Exploring decisional control preferences in older patients with cancer and their caregivers.. Journal of Clinical Oncology. 41(16_suppl). 12042–12042. 1 indexed citations
2.
Culakova, Eva, Supriya G. Mohile, Luke J. Peppone, et al.. (2022). Effects of a Geriatric Assessment Intervention on Patient-Reported Symptomatic Toxicity in Older Adults With Advanced Cancer. Journal of Clinical Oncology. 41(4). 835–846. 17 indexed citations
3.
Hershman, Dawn L., Aasthaa Bansal, Sean D. Sullivan, et al.. (2022). A Pragmatic Cluster-Randomized Trial of a Standing Order Entry Intervention for Colony-Stimulating Factor Use Among Patients at Intermediate Risk for Febrile Neutropenia. Journal of Clinical Oncology. 41(3). 590–598. 3 indexed citations
4.
Ingle, James N., Mohan Liu, D. Lawrence Wickerham, et al.. (2013). Selective Estrogen Receptor Modulators and Pharmacogenomic Variation in ZNF423 Regulation of BRCA1 Expression: Individualized Breast Cancer Prevention. Cancer Discovery. 3(7). 812–825. 56 indexed citations
5.
Gupta, Sameer, et al.. (2012). Survival Outcomes in Pregnancy Associated Breast Cancer: A Retrospective Case Control Study. The Breast Journal. 18(2). 139–144. 41 indexed citations
6.
Vogel, Victor G., Joseph P. Costantino, D. Lawrence Wickerham, et al.. (2010). Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer. Cancer Prevention Research. 3(6). 696–706. 438 indexed citations
7.
Swain, Sandra M., Jong‐Hyeon Jeong, Charles E. Geyer, et al.. (2010). Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast Cancer. Obstetrical & Gynecological Survey. 65(11). 710–712. 10 indexed citations
8.
Vogel, Victor G.. (2009). Epidemiología, genética y evaluación del riesgo de cáncer de mama en mujeres posmenopáusicas. 12(70). 121–133.
9.
Vogel, Victor G.. (2008). Managing the risk of breast cancer in postmenopausal women. Menopause The Journal of The North American Menopause Society. 15(4). 779–781. 1 indexed citations
10.
Vogel, Victor G.. (2006). Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes<SUBTITLE>The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial</SUBTITLE>. JAMA. 295(23). 2727–2727. 1117 indexed citations breakdown →
11.
Land, Stephanie R., D. Lawrence Wickerham, Joseph P. Costantino, et al.. (2006). Patient-Reported Symptoms and Quality of Life During Treatment With Tamoxifen or Raloxifene for Breast Cancer Prevention. The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial. Obstetrical & Gynecological Survey. 61(10). 651–653. 58 indexed citations
12.
Okobia, Michael, Clareann H. Bunker, Joseph M. Zmuda, et al.. (2006). Case–control study of risk factors for breast cancer in Nigerian women. International Journal of Cancer. 119(9). 2179–2185. 45 indexed citations
13.
Vogel, Victor G., et al.. (2005). Prognostic factors for breast cancer and their use in the clinical setting. Expert Review of Anticancer Therapy. 5(2). 269–281. 8 indexed citations
14.
Tan-Chiu, Elizabeth, Greg Yothers, Edward H. Romond, et al.. (2005). Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: NSABP B-31. Journal of Clinical Oncology. 23(31). 7811–7819. 568 indexed citations breakdown →
15.
Key, T J & Victor G. Vogel. (2004). Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. Breast Diseases A Year Book Quarterly. 15. 33. 8 indexed citations
16.
Gansera, Brigitte, et al.. (2004). Is There a Difference Between Diabetic and Non-Diabetic ITAs? Histomorphological and Immunohistochemical Examinations of Internal Thoracic Arteries. The Thoracic and Cardiovascular Surgeon. 52(5). 255–260. 4 indexed citations
17.
Vogel, Victor G., Joseph P. Costantino, D. Lawrence Wickerham, & Walter M. Cronin. (2003). National Surgical Adjuvant Breast and Bowel Project Update. Clinical Cancer Research. 9(1). 1 indexed citations
18.
Vogel, Victor G., et al.. (1997). Breast cancer screening. Cancer and Metastasis Reviews. 16(3-4). 231–262. 16 indexed citations
19.
Vogel, Victor G., et al.. (1993). Evaluation of risk and preventive approaches to breast cancer. 45(6). 489–494. 4 indexed citations
20.
Bondy, Melissa L., Margaret R. Spitz, Susan Halabi, John J. Fueger, & Victor G. Vogel. (1992). Low incidence of familial breast cancer among Hispanic women. Cancer Causes & Control. 3(4). 377–382. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Forbes Breakdown of academic impact, for papers by Vered Stearns Breakdown of academic impact, for papers by Claudine Isaacs Breakdown of academic impact, for papers by Michael Baum Breakdown of academic impact, for papers by Thomas A. Sellers Breakdown of academic impact, for papers by James N. Atkins Breakdown of academic impact, for papers by Beat Thürlimann Breakdown of academic impact, for papers by André Robidoux Breakdown of academic impact, for papers by Kathleen E. Malone Breakdown of academic impact, for papers by Paul E. Goss
Rankless by CCL
2026